Inflammation-targeting polyamine nanomedicines for the treatment of ulcerative colitis
Open Access
- 5 April 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 11 (18) , 4005-4013
Abstract
Orally administered anti-inflammatory polyamine-based nanomedicines are presented. Inflammation-targeting, radical scavenging, and biocompatible nanomedicines may serve as therapeutic drugs for inflammatory diseases.Keywords
Funding Information
- Japan Society for the Promotion of Science (grant numbers 22K19947, 22H03962, 20H02470)
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 32 references indexed in Scilit:
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- Inducing and Maintaining Remission in Ulcerative ColitisJournal of Clinical Gastroenterology, 2010
- Toll-like receptors in inflammatory bowel diseases: A decade laterInflammatory Bowel Diseases, 2010
- Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic MucosaMolecular Pharmaceutics, 2009
- Design of Core−Shell-Type Nanoparticles Carrying Stable Radicals in the CoreBiomacromolecules, 2009
- NF‐κB in inflammatory bowel diseaseJournal of Internal Medicine, 2008
- Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary PreventionJAMA, 2007
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Shaping the nuclear action of NF-κBNature Reviews Molecular Cell Biology, 2004
- NF-κB regulation in the immune systemNature Reviews Immunology, 2002